Elena Santagostino - Swedish Orphan Biovitrum AB Sobi

基本信息

浏览量：138

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 619 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Perioperative Management with Efanesoctocog Alfa in Patients with Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies

Robert Klamroth,Annette von Drygalski,Cedric Hermans,Young-Shil Park,Anthony K C Chan,Alphan Kupesiz,María Teresa Alvarez-Román,Lynn Malec,Elena Santagostino, Graham Neill,Linda Bystrická, Jennifer Dumont,Lydia Abad-Franch, Lila-Sabrina Fetita,Liane Khoo

Haemophilia the official journal of the World Federation of Hemophiliano. 3 (2025): 391-400

引用0浏览0WOS引用

Real-world Usage and Effectiveness of Recombinant Factor IX Fc in Haemophilia B from the B-SURE Study in France

Hervé Chambost,Yohann Repessé,Fabienne Genre-Volot,Dominique Desprez, Sabine Marie Castet,Stéphane Vanderbecken, Meriem Zidi, Corinne Gandossi, Eveline Nüesch, Helena Palmborg,Elena Santagostino, B-SURE Study Group

Therapeutic advances in hematology (2025): 20406207241311535-20406207241311535

引用0浏览0WOS引用

Real-world effectiveness and usage of recombinant factor IX Fc: Interim analysis in paediatric patients from the 24-month, prospective, non-interventional B-MORE study

H. Glosli,H. Pergantou,B. Nolan,R. Berrueco,S. Ranta, M. Al Saleh,S. Lauer,E. Bednar,E. Gresko,E. Santagostino

HAEMOPHILIA（2024）

引用0浏览0引用

Treatment Preferences in Previously Treated Patients with Haemophilia A: Phase 3 XTEND-1 Study of Efanesoctocog Alfa

E. Spasov,D. Quon,K. Fukutake,J. Msihid,A. Willemze, J. Dumont, H. Palmborg,N. Kragh, A. Wilson

HAEMOPHILIA (2024): 96-96

引用0浏览0引用

Change in Hemophilia Joint Health Score (HJHS) During the Phase 3 XTEND-1 Study of Efanesoctocog Alfa in Patients with Severe Hemophilia A

A. Wilson,L. Nemes, D. V. Quon,O. Katsarou,N. Kragh, J. Dumont,J. Msihid, C. Zhang,E. Santagostino,A. Willemze

Hämostaseologie (2024)

引用0浏览0引用

Efanesoctocog Alfa Treatment Outcomes in Subjects ≥50 Years of Age from the Xtend-1 Trial

Johannes Oldenburg,Barbara Konkle,Toshko Lissitchkov,Pratima Chowdary,Liane Khoo,Olga Katsarou,Katsuyuki Fukutake,Annette von Drygalski,Elena Santagostino, Helena Palmborg,Linda Bystricka,Jennifer Dumont,Alejandro Fernandez,Sriya Gunawardena

HAEMOPHILIA (2024): 93-94

引用0浏览0引用

Interim Analysis of Real-World Effectiveness and Usage of Recombinant Factor IX Fc for Surgical Haemostasis from the 24-Month Prospective, Non-Interventional B-MORE Study

H. Glosli,F. Peyvandi,D. Allsup,O. Katsarou,R. Berrueco,E. Bednar,S. Lauer,E. Gresko,E. Santagostino

HAEMOPHILIA (2024): 55-56

引用0浏览0引用

Real-world Usage and Effectiveness of Recombinant Factor VIII/factor IX Fc in Hemophilia A/B: Final Data from the 24-Month, Prospective, Non-Interventional PREVENT Study in Germany

Christoph Bidlingmaier,Christine Heller,Florian Langer,Wolfgang Miesbach,Ute Scholz,Johannes Oldenburg, Eveline Nueesch, Helena Palmborg,Elena Santagostino,Andreas Tiede

Research and Practice in Thrombosis and Haemostasisno. 5 (2024): 102482-102482

引用0浏览0WOS引用

Efanesoctocog Alfa Prophylaxis Outcomes in European Patients from the XTEND-1 Trial

S. Susen,J. Oldenburg,C. Koenigs,F. Peyvandi, U. Khan,L. Bystricka,E. Santagostino,L. Abad-Franch,P. Chowdary

HAEMOPHILIA (2024): 90-91

引用0浏览0引用

Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A

NEW ENGLAND JOURNAL OF MEDICINEno. 3 (2024): 235-246

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn